The FTC Goes Evidence-Free
Lina Khan’s newest strategy is to ignore years of scholarship that proves the value of Pharmacy Benefit Managers.
Lina Khan’s newest strategy is to ignore years of scholarship that proves the value of Pharmacy Benefit Managers.